Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment

Andrade, Stephanie, Ramalho, Maria João, Pereira, Maria do Carmo, Loureiro, Joana A.·2018·Frontiers in Pharmacology
DOI 10.3389/fphar.2018.01261

Cites (243)

Items 201–240 of 240

  1. Resveratrol loaded PLGA: d -α-tocopheryl polyethylene glycol 1000 succinate blend nanoparticles for brain cancer therapy
    Mahalingam Rajamanickam Vijayakumar, Ramoji Kosuru, Sanjay Kumar Singh, Chandra Bhushan Prasad, Gopeshwar Narayan, Madaswamy Sona Muthu, Sanjay Kumar Singh · 2016 · RSC Advances
  2. Stability of the Transthyretin Molecule as a Key Factor in the Interaction with A-Beta Peptide - Relevance in Alzheimer's Disease
    Carlos A. Ribeiro, Maria João Saraiva, Isabel Cardoso · 2012 · PLoS ONE
  3. Resveratrol reduces oxidative stress and cell death and increases mitochondrial antioxidants and XIAP in PC6.3-cells
    Minna Kairisalo, Alessandra Bonomo, Alise Hyrskyluoto, Giuseppa Mudò, Natale Belluardo, Laura Korhonen, Dan Lindholm · 2010 · Neuroscience Letters
  4. Dominant Carbons in trans- and cis-Resveratrol Isomerization
    Feng Wang, Subhojyoti Chatterjee · 2017 · The Journal of Physical Chemistry B
  5. Possible Role of Resveratrol Targeting Estradiol and Neprilysin Pathways in Lipopolysaccharide Model of Alzheimer Disease
    Nesrine S. El Sayed, Yasmeen Bayan · 2014 · Advances in experimental medicine and biology
  6. Protection effect of piperine and piperlonguminine from Piper longum L. alkaloids against rotenone-induced neuronal injury
    Hao Wang, Jia Liu, Ge Gao, Xia Wu, Xiaomin Wang, Hui Yang · 2015 · Brain Research
  7. Trans resveratrol loaded DSPE PEG 2000 coated liposomes: An evidence for prolonged systemic circulation and passive brain targeting
    Mahalingam Rajamanickam Vijayakumar, Ramoji Kosuru, Parameswara Rao Vuddanda, Sanjay Kumar Singh, Sanjay Singh · 2016 · Journal of Drug Delivery Science and Technology
  8. Mast cells modulate proliferation, migration and stemness of glioma cells through downregulation of GSK3β expression and inhibition of STAT3 activation
    Sanaz Attarha, Ananya Roy, Bengt Westermark, Elena Tchougounova · 2017 · Cellular Signalling
  9. Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation
    Hao Li, YAODONG LIU, YUMIN JIAO, Anchen Guo, Xiaoxue Xu, Xian‐Jun Qu, Shuo Wang, Jizong Zhao, Ye Li, Yong Bao Cao · 2015 · Oncology Reports
  10. Rotenone induced neurotoxicity in rat brain areas: A histopathological study
    Supriya Swarnkar, Sarika Singh, Sharad Sharma, Ramesh Mathur, Ishan Kumar Patro, Chandishwar Nath · 2011 · Neuroscience Letters
  11. Preparation and Characterization of Polymeric Nanoparticles: An Interdisciplinary Experiment
    Maria João Ramalho, Maria do Carmo Pereira · 2016 · Journal of Chemical Education
  12. Resveratrol reduces TNF-α-induced U373MG human glioma cell invasion through regulating NF-κB activation and uPA/uPAR expression.
    Jinhyun Ryu, Bo Mi Ku, Yeon Kyung Lee, Joo Yeon Jeong, Seok‐Min Kang, Jungil Choi, Yang Yeong-Ae, Dong Hoon Lee, Gu Seob Roh, Hyun Joon Kim et al. · 2011 · PubMed
  13. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery
    Yu Xin, Tie Liu, Chenlong Yang · 2016 · International Journal of Nanomedicine
  14. Resveratrol protects against 4‐HNE induced oxidative stress and apoptosis in Swiss 3T3 fibroblasts
    Özgür Kütük, Mazhar Adli, Giuseppe Poli, Hüveyda Başağa · 2004 · BioFactors
  15. Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells
    Wei Zhang, Zhou Fei, Haining Zhen, Jianning Zhang, Xiang Zhang · 2006 · Journal of Neuro-Oncology
  16. Resveratrol Intervenes Cholesterol- and Isoprenoid-Mediated Amyloidogenic Processing of AβPP in Familial Alzheimer’s Disease
    Mohan Sathya, Moorthi Ponnusamy, Premkumar Palanisamy, Mahesh Kandasamy, Kesavan Swaminathan Jayachandran, Muthuswamy Anusuyadevi · 2017 · Journal of Alzheimer s Disease
  17. Heme oxygenase 1: Another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule
    Stéphane Bastianetto, Rémi Quirion · 2010 · Experimental Neurology
  18. Tissue Distribution oftrans-Resveratrol and Its Metabolites after Oral Administration in Human Eyes
    Shuaishuai Wang, Zheng Wang, Shuo Yang, Tiemei Yin, Yaoli Zhang, Yuanjun Qin, Robert Neal Weinreb, Xufang Sun · 2017 · Journal of Ophthalmology
  19. Synergistic anti-glioma effect of a coloaded nano-drug delivery system
    Huae Xu, Feng Jia, Pankaj Kumar Singh, Shu Ruan, Hao Zhang, Xiaolin Li · 2016 · International Journal of Nanomedicine
  20. Blood–brain interfaces and cerebral drug bioavailability
    Jean‐François Ghersi‐Egea, Kati Mönkkönen, Charlotte Schmitt, Jérôme Honnorat, Michelle Fèvre‐Montange, Nathalie Strazielle · 2009 · Revue Neurologique
  21. Immunoliposomes Doubly Targeted to Transferrin Receptor and to α-Synuclein
    Joana A. Loureiro, Bárbara Gomes, Manuel A. N. Coelho, Maria do Carmo Pereira, Sandra Rocha · 2015 · Future Science OA
  22. Peptide-surfactant interactions: consequences for the amyloid-beta structure.
    S. Rocha, J. Loureiro, G. Brezesinski, M. Pereira · 2012 · Biochemical and Biophysical Research Communications - BBRC
  23. Unique vascular protective properties of natural products: supplements or future main-line drugs with significant anti-atherosclerotic potential?
    MARK A. SLEVIN, Nessar Ahmed, Qiuyu Wang, Garry McDowell, Lina Badimón · 2012 · Vascular Cell
  24. Preparation, Characterization, and Antitumor Evaluation of Electrospun Resveratrol Loaded Nanofibers
    Hui Zhou, Xiaoxing Liu, Fenglei Wu, Junting Zhang, Zhen Wu, Haitao Yin, Hui Shi · 2016 · Journal of Nanomaterials
  25. Charged surfactants induce a non‐fibrillar aggregation pathway of amyloid‐beta peptide
    J. Loureiro, S. Rocha, Maria Do Carmo Pereira · 2013 · Journal of Peptide Science
  26. Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response
    Stuart James Smith, Jennifer H. Ward, Christopher Tan, Richard Guy Grundy, Ruman Rahman · 2015 · Oncotarget
  27. Resveratrol for Alzheimer’s disease?
    Ian Martin · 2017 · Science Translational Medicine
  28. Therapeutic approach beyond conventional temozolomide for newly diagnosed glioblastoma: Review of the present evidence and future direction
    Supriya Mallick, Ajeet Kumar Gandhi, Goura Kishor Rath · 2015 · Indian Journal of Medical and Paediatric Oncology
  29. (R)‐α‐trifluoromethylalanine containing short peptide in the inhibition of amyloid peptide fibrillation
    Alexandra Botz, V. Gasparik, Emmanuelle Devillers, Anais R. F. Hoffmann, L. Caillon, E. Chelain, O. Lequin, T. Brigaud, Lucie Khemtemourian · 2015 · Biopolymers
  30. PLGA nanoparticles for calcitriol delivery
    Maria João Ramalho, Joana A. Loureiro, Bárbara Gomes, Manuela F. Frasco, Manuel A. N. Coelho, Maria do Carmo Pereira · 2015 · IEEE Portuguese Meeting on Bioengineering
  31. Interaction studies of amyloid beta-peptide with the natural compound resveratrol
    Stéphanie Andrade, Joana A. Loureiro, Manuel A. N. Coelho, Maria do Carmo Pereira · 2015 · IEEE Portuguese Meeting on Bioengineering
  32. Nanocarriers for the delivery of temozolomide in the treatment of glioblastoma
    Maria João Ramalho, Manuel A. N. Coelho, Maria do Carmo Pereira · 2018 · Elsevier eBooks
  33. Influence of Drug Lipophilicity on Drug Release from Sclera After Iontophoretic Delivery of Mixed Micellar Carrier System to Human Sclera
    Poonam Chopra, Jinsong Hao, S. Kevin Li · 2012 · Journal of Pharmaceutical Sciences
  34. Nanocarriers for Resveratrol Delivery
    Divya Arora, Sundeep Jaglan · 2017 · Sustainable agriculture reviews
  35. A glass of red wine to improve mitochondrial biogenesis? Novel mechanisms of resveratrol
    Gabor B. Szabo · 2009 · American Journal of Physiology-Heart and Circulatory Physiology
  36. Cyclin D1 Co-localizes with Beclin-1 in Glioblastoma Recurrences: A Clue to a Therapy-induced, Autophagy-mediated Degradative Mechanism?
    Luigi Pirtoli, Giuseppe Belmonte, Marzia Toscano, Paolo Tini, Clelia Miracco · 2016 · PubMed
  37. The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer’s Disease
    Bárbara Gomes, Joana A. Loureiro, Manuel A. N. Coelho, Maria do Carmo Pereira · 2015 · Current Pharmaceutical Design
  38. Carbohydrate particles as protein carriers and scaffolds: physico-chemical characterization and collagen stability
    Ivone Peres, Sandra Rocha, Joana A. Loureiro, Maria do Carmo Pereira, Galya I. Ivanova, Manuel A. N. Coelho · 2012 · Journal of Nanoparticle Research
  39. Design of potential therapeutic peptides and carriers to inhibit amyloid β peptide aggregation
    Joana A. Loureiro, Manuel A. N. Coelho, Sandra Rocha, Maria do Carmo Pereira · 2012 · IEEE Portuguese Meeting on Bioengineering
  40. Immunoliposomes for Alzheimer's disease therapy
    Joana A. Loureiro, Bárbara Gomes, Manuel A. N. Coelho, Maria do Carmo Pereira, Sandra Rocha · 2013 · IEEE Portuguese Meeting on Bioengineering